Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients
- PMID: 31906903
- PMCID: PMC6945698
- DOI: 10.1186/s12888-019-2411-1
Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients
Erratum in
-
Correction to: Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.BMC Psychiatry. 2020 Mar 26;20(1):136. doi: 10.1186/s12888-020-02534-y. BMC Psychiatry. 2020. PMID: 32216784 Free PMC article.
Abstract
Background: Effective transdiagnostic treatments for patients presenting with principal or comorbid symptoms of anxiety and depression enable more efficient provision of mental health care and may be particularly suitable for the varied population seen in primary healthcare settings. Mindfulness-integrated cognitive behavior therapy (MiCBT) is a transdiagnostic intervention that integrates aspects of CBT, including exposure skills targeting avoidance, with training in mindfulness meditation skills adopted from the Vipassana or insight tradition taught by the Burmese teachers U Ba Khin and Goenka. MiCBT is distinguished from both cognitive therapy and mindfulness-based cognitive therapy by the use of a theoretical framework which proposes that the locus of reinforcement of behavior is the interoceptive experience (body sensations) that co-arises with self-referential thinking. Consequently, MiCBT has a strong focus on body scanning to develop interoceptive awareness and equanimity. Designed for clinical purposes, the four-stage systemic approach of MiCBT, comprising intra-personal (Stage 1) exposure (Stage 2), interpersonal (Stage 3), and empathic (Stage 4) skillsets, is a distinguishing feature among other mindfulness-based interventions (MBIs). The aim of this study is to investigate whether and how group MiCBT decreases depression and anxiety symptoms for patients with a range of common mental health conditions.
Methods: Participants (n = 120) recruited via medical practitioner referral will be randomized to MiCBT or a wait-list control. Inclusion criteria are age 18-75; fluent in English and having a Kessler Psychological Distress Scale (K10) score of 20 or more. The MiCBT treatment group receive an 8-week MiCBT intervention delivered in a private psychology practice. Participants complete a suite of online self-report measures and record the amount of meditation practice undertaken each week. The control group receive usual treatment and complete the measures at the same time points. Primary outcome measures are the Depression Anxiety Stress Scale-21 (DASS-21) and K10. Analysis will use mixed-model repeated measures.
Discussion: The potential ability of MiCBT to provide a comprehensive therapeutic system that is applicable across diagnostic groups would make it an attractive addition to the available MBIs.
Trial registration: This trial is registered with the Australia and New Zealand Clinical Trials Registry: ACTRN12617000061336; Date of registration: 11th January 2017.
Keywords: Anxiety; Depression; Equanimity; Group therapy; MiCBT; Mindfulness; Mindfulness-based intervention; Mindfulness-integrated cognitive behavior therapy; Transdiagnostic.
Conflict of interest statement
Dr. Cayoun receives royalties from Wiley Blackwell Press for MiCBT publications outside the submitted work and fees for MiCBT professional training workshops. Sarah Francis receives royalties from Wiley Blackwell Press for MiCBT publications outside the submitted work.
Figures
Similar articles
-
Group Mindfulness-Integrated Cognitive Behavior Therapy (MiCBT) Reduces Depression and Anxiety and Improves Flourishing in a Transdiagnostic Primary Care Sample Compared to Treatment-as-Usual: A Randomized Controlled Trial.Front Psychiatry. 2022 May 31;13:815170. doi: 10.3389/fpsyt.2022.815170. eCollection 2022. Front Psychiatry. 2022. PMID: 35711582 Free PMC article.
-
Low-Intensity Guided Help Through Mindfulness (LIGHTMIND): study protocol for a randomised controlled trial comparing supported mindfulness-based cognitive therapy self-help to supported cognitive behavioural therapy self-help for adults experiencing depression.Trials. 2020 May 4;21(1):374. doi: 10.1186/s13063-020-04322-1. Trials. 2020. PMID: 32366320 Free PMC article.
-
A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.BMC Psychiatry. 2018 Oct 3;18(1):320. doi: 10.1186/s12888-018-1898-1. BMC Psychiatry. 2018. PMID: 30285672 Free PMC article. Clinical Trial.
-
Differentiating mindfulness-integrated cognitive behavior therapy and mindfulness-based cognitive therapy clinically: the why, how, and what of evidence-based practice.Front Psychol. 2024 Feb 6;15:1342592. doi: 10.3389/fpsyg.2024.1342592. eCollection 2024. Front Psychol. 2024. PMID: 38384351 Free PMC article. Review.
-
Mindfulness and bodily distress.Dan Med J. 2012 Nov;59(11):B4547. Dan Med J. 2012. PMID: 23171754 Review.
Cited by
-
Study protocol for the family empowerment program: a randomized waitlist-controlled trial to evaluate the effectiveness of online Community Reinforcement and Family Training (CRAFT) on the wellbeing of family members with a relative experiencing substance dependence and mental illness.BMC Psychiatry. 2024 Jan 10;24(1):43. doi: 10.1186/s12888-023-05487-0. BMC Psychiatry. 2024. PMID: 38200508 Free PMC article.
-
Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial.Front Psychiatry. 2023 Mar 14;14:1034246. doi: 10.3389/fpsyt.2023.1034246. eCollection 2023. Front Psychiatry. 2023. PMID: 36998625 Free PMC article.
-
Social connectedness, mindfulness, and coping as protective factors during the COVID-19 pandemic.J Couns Dev. 2022 Jun 8:10.1002/jcad.12450. doi: 10.1002/jcad.12450. Online ahead of print. J Couns Dev. 2022. PMID: 35942199 Free PMC article.
-
Group Mindfulness-Integrated Cognitive Behavior Therapy (MiCBT) Reduces Depression and Anxiety and Improves Flourishing in a Transdiagnostic Primary Care Sample Compared to Treatment-as-Usual: A Randomized Controlled Trial.Front Psychiatry. 2022 May 31;13:815170. doi: 10.3389/fpsyt.2022.815170. eCollection 2022. Front Psychiatry. 2022. PMID: 35711582 Free PMC article.
-
Relationships between interoceptive sensibility and resting-state functional connectivity of the insula in obsessive-compulsive disorder.Cereb Cortex. 2022 Nov 21;32(23):5285-5300. doi: 10.1093/cercor/bhac014. Cereb Cortex. 2022. PMID: 35257146 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials